Abstract
Alzheimer’s disease (AD) is the most common form of dementia among the elderly. Amyloid-β (Aβ) accumulation and the downstream pathological events, such as neurofibrillary tangles, neuron loss, neurite degeneration, as well as cognitive dysfunction, are hallmarks of the disease. Until now, the pathogenesis of AD is not fully understood, and no disease-modifying interventions are currently available. Recent studies suggest that the neurotrophin receptor p75 (p75NTR), a receptor for Aβ, is a key factor involved in AD pathogenesis. While more potential functions of p75NTR remain to be discovered, this review tried to elaborate the diverse roles of p75NTR in AD, providing a promising therapeutic target for the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- APP:
-
Amyloid precursor protein
- Aβ:
-
Amyloid-β
- BACE1:
-
Beta-site amyloid precursor protein cleaving enzyme-1
- BBB:
-
Blood-brain barrier
- BDNF:
-
Brain-derived neurotrophic factor
- CNS:
-
Central nervous system
- CRD:
-
Cysteine-rich domain
- CSF:
-
Cerebrospinal fluid
- CTF:
-
C-terminal fragment
- DRG:
-
Dorsal root ganglion
- EAE:
-
Experimental allergic encephalomyelitis
- ECD:
-
Extracellular domain
- GCP:
-
Granule cell progenitor
- HD:
-
Huntington’s disease
- ICD:
-
Intracellular domain
- IGF-1R:
-
Growth factor 1 receptor
- LTD:
-
Long-term depression
- MAG:
-
Myelin-associated glycoprotein
- NBM:
-
Nucleus basalis of Meynert
- NFT:
-
Neurofibrillary tangle
- NT:
-
Neurotrophin
- p75NTR:
-
The neurotrophin receptor p75
- PNS:
-
Peripheral nervous system
- RGC:
-
Retinal ganglion cell
- TACE:
-
Tumor necrosis factor-alpha converting enzyme
- TNF:
-
Tumor necrosis factor
- Trk:
-
Tropomyosin receptor kinase
References
Allard, S., Jacobs, M. L., Do Carmo, S., & Cuello, A. C. (2018). Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons. Neurobiology of Aging, 67, 10–20.
Bai, Y., Dergham, P., Nedev, H., Xu, J., Galan, A., Rivera, J. C., Zhihua, S., Mehta, H. M., Woo, S. B., Sarunic, M. V., Neet, K. E., & Saragovi, H. U. (2010). Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. The Journal of Biological Chemistry, 285, 39392–39400.
Bengoechea, T. G., Chen, Z., O’leary, D., Masliah, E., & Lee, K. F. (2009). p75 reduces beta-amyloid-induced sympathetic innervation deficits in an Alzheimer’s disease mouse model. Proceedings of the National Academy of Sciences of the United States of America, 106, 7870–7875.
Brito, V., Puigdellivol, M., Giralt, A., Del Toro, D., Alberch, J., & GINES, S. (2013). Imbalance of p75(NTR)/TrkB protein expression in Huntington’s disease: Implication for neuroprotective therapies. Cell Death & Disease, 4, e595.
Brito, V., Giralt, A., Enriquez-Barreto, L., Puigdellivol, M., Suelves, N., Zamora-Moratalla, A., Ballesteros, J. J., Martin, E. D., Dominguez-Iturza, N., Morales, M., Alberch, J., & Gines, S. (2014). Neurotrophin receptor p75(NTR) mediates Huntington’s disease-associated synaptic and memory dysfunction. The Journal of Clinical Investigation, 124, 4411–4428.
Chakravarthy, B., Gaudet, C., Menard, M., Atkinson, T., Brown, L., Laferla, F. M., Armato, U., & Whitfield, J. (2010). Amyloid-beta peptides stimulate the expression of the p75NTR neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. Journal of Alzheimer’s Disease, 19, 915–925.
Chakravarthy, B., Menard, M., Ito, S., Gaudet, C., Dal Pra, I., Armato, U., & Whitfield, J. (2012). Hippocampal membrane-associated p75NTR levels are increased in Alzheimer’s disease. Journal of Alzheimer’s Disease, 30, 675–684.
Coulson, D. T., Beyer, N., Quinn, J. G., Brockbank, S., Hellemans, J., Irvine, G. B., Ravid, R., & Johnston, J. A. (2010). BACE1 mRNA expression in Alzheimer’s disease postmortem brain tissue. Journal of Alzheimer’s Disease, 22, 1111–1122.
Coulson, E. J., Simmons, D. A., Knowles, J. K., Belichenko, N. P., Banerjee, G., Finkle, C., Massa, S. M., & Longo, F. M. (2014). A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer’s disease mouse models with mid- to late-stage disease progression. PLoS One, 9, e102136.
Cragnolini, A. B., Volosin, M., Huang, Y., & Friedman, W. J. (2012). Nerve growth factor induces cell cycle arrest of astrocytes. Developmental Neurobiology, 72, 766–776.
Dias Bda, C., Jovanovic, K., Gonsalves, D., & Weiss, S. F. (2011). Structural and mechanistic commonalities of amyloid-beta and the prion protein. Prion, 5, 126–137.
Finan, G. M., Okada, H., & Kim, T. W. (2011). BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. Journal of Biological Chemistry, 286, 12602–12616.
Gao, C., Zhang, L., Sun, D., Li, J., Yao, X., Zhou, H., & Wang, Y. (2017). Roles of p75NTR in maintaining brain hemostasis and the implications for p75NTR-targeted therapies. Current Alzheimer Research, 14, 554–561.
Geetha, T., Zheng, C., Mcgregor, W. C., Douglas White, B., Diaz-Meco, M. T., Moscat, J., & Babu, J. R. (2012). TRAF6 and p62 inhibit amyloid beta-induced neuronal death through p75 neurotrophin receptor. Neurochemistry International, 61, 1289–1293.
Iijima, K. M., Hasebe, N., Fujita, Y., Ueno, M., Yoshimura, K., Fujino, Y., & Yamashita, T. (2013). Soluble β-amyloid precursor protein alpha binds to p75 neurotrophin receptor to promote neurite outgrowth. PLoS One, 8, e82321.
Ioannou, M. S., & Fahnestock, M. (2017). ProNGF, but not NGF, switches from neurotrophic to apoptotic activity in response to reductions in TrkA receptor levels. International Journal of Molecular Sciences, 18, 599.
Ito, S., Menard, M., Atkinson, T., Gaudet, C., Brown, L., Whitfield, J., & Chakravarthy, B. (2012). Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-beta peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse hippocampus. Journal of Alzheimer’s Disease, 31, 493–506.
Jian, C., Zou, D., Luo, C., Liu, X., Meng, L., Huang, J., Li, X., Huang, R., & Wu, Y. (2016). Cognitive deficits are ameliorated by reduction in amyloid beta accumulation in Tg2576/p75(NTR+/−) mice. Life Sciences, 155, 167–173.
Knowles, J. K., Rajadas, J., Nguyen, T. V., Yang, T., Lemieux, M. C., Vander Griend, L., Ishikawa, C., Massa, S. M., Wyss-Coray, T., & Longo, F. M. (2009). The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. The Journal of Neuroscience, 29, 10627–10637.
Knowles, J. K., Simmons, D. A., Nguyen, T. V., Vander Griend, L., Xie, Y., Zhang, H., Yang, T., Pollak, J., Chang, T., Arancio, O., Buckwalter, M. S., Wyss-Coray, T., Massa, S. M., & Longo, F. M. (2013). Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer’s mouse model. Neurobiology of Aging, 34, 2052–2063.
Kraemer, B. R., Snow, J. P., Vollbrecht, P., Pathak, A., Valentine, W. M., Deutch, A. Y., & Carter, B. D. (2014a). A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress. The Journal of Biological Chemistry, 289, 21205–21216.
Kraemer, B. R., Yoon, S. O., & Carter, B. D. (2014b). The biological functions and signaling mechanisms of the p75 neurotrophin receptor. Handbook of Experimental Pharmacology, 220, 121–164.
Mañucat-Tan, N. B., Shen, L.-L., Bobrovskaya, L., Al-Hawwas, M., Zhou, F. H., Wang, Y.-J., & Zhou, X.-F. (2019). Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model. Aging, 11, 6762–6791.
Martinowich, K., Schloesser, R. J., Lu, Y., Jimenez, D. V., Paredes, D., Greene, J. S., Greig, N. H., Manji, H. K., & Lu, B. (2012). Roles of p75(NTR), long-term depression, and cholinergic transmission in anxiety and acute stress coping. Biological Psychiatry, 71, 75–83.
Meeker, R., & Williams, K. (2014). Dynamic nature of the p75 neurotrophin receptor in response to injury and disease. Journal of Neuroimmune Pharmacology, 9, 615–628.
Morillo, S. M., Escoll, P., De La Hera, A., & Frade, J. M. (2010). Somatic tetraploidy in specific chick retinal ganglion cells induced by nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America, 107, 109–114.
Morillo, S. M., Abanto, E. P., Roman, M. J., & Frade, J. M. (2012). Nerve growth factor-induced cell cycle reentry in newborn neurons is triggered by p38MAPK-dependent E2F4 phosphorylation. Molecular and Cellular Biology, 32, 2722–2737.
Mufson, E. J., Counts, S. E., Ginsberg, S. D., Mahady, L., Perez, S. E., Massa, S. M., Longo, F. M., & Ikonomovic, M. D. (2019). Nerve growth factor pathobiology during the progression of Alzheimer’s disease. Frontiers in Neuroscience, 13, 533.
Murphy, M., Wilson, Y. M., Vargas, E., Munro, K. M., Smith, B., Huang, A., Li, Q. X., Xiao, J., Masters, C. L., Reid, C. A., & Barrett, G. L. (2015). Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer’s disease. Neurobiology of Aging, 36, 740–752.
Nguyen, T. V., Shen, L., Vander Griend, L., Quach, L. N., Belichenko, N. P., Saw, N., Yang, T., Shamloo, M., Wyss-Coray, T., Massa, S. M., & Longo, F. M. (2014). Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AbetaPP(L/S) transgenic mice. Journal of Alzheimer’s Disease, 42, 459–483.
Ovsepian, S. V., Antyborzec, I., O’leary, V. B., Zaborszky, L., Herms, J., & Oliver Dolly, J. (2014). Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Abeta) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. Brain Structure & Function, 219, 1527–1541.
Pincheira, R., Baerwald, M., Dunbar, J. D., & Donner, D. B. (2009). Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth. The EMBO Journal, 28, 261–273.
Qian, L., Milne, M. R., Shepheard, S., Rogers, M. L., Medeiros, R., & Coulson, E. J. (2019). Removal of p75 neurotrophin receptor expression from cholinergic basal forebrain neurons reduces amyloid-beta plaque deposition and cognitive impairment in aged APP/PS1 mice. Molecular Neurobiology, 56, 4639–4652.
Riffault, B., Kourdougli, N., Dumon, C., Ferrand, N., Buhler, E., Schaller, F., Chambon, C., Rivera, C., Gaiarsa, J. L., & Porcher, C. (2016). Pro-brain-derived neurotrophic factor (proBDNF)-mediated p75NTR activation promotes depolarizing actions of GABA and increases susceptibility to epileptic seizures. Cerebral Cortex, 28, 510–527.
Saadipour, K., Manucat-Tan, N. B., Lim, Y., Keating, D. J., Smith, K. S., Zhong, J. H., Liao, H., Bobrovskaya, L., Wang, Y. J., Chao, M. V., & Zhou, X. F. (2018). p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis. Journal of Neurochemistry, 144, 302–317.
Shen, L. L., Manucat-Tan, N. B., Gao, S. H., Li, W. W., Zeng, F., Zhu, C., Wang, J., Bu, X. L., Liu, Y. H., Gao, C. Y., Xu, Z. Q., Bobrovskaya, L., Lei, P., Yu, J. T., Song, W., Zhou, H. D., Yao, X. Q., Zhou, X. F., & Wang, Y. J. (2018). The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau. Molecular Psychiatry, 23, 1813–1824.
Shen, L.-L., Li, W.-W., Xu, Y.-L., Gao, S.-H., Xu, M.-Y., Bu, X.-L., Liu, Y.-H., Wang, J., Zhu, J., Zeng, F., Yao, X.-Q., Gao, C.-Y., Xu, Z.-Q., Zhou, X.-F., & Wang, Y.-J. (2019). Neurotrophin receptor p75 mediates amyloid β-induced tau pathology. Neurobiology of Disease, 132, 104567.
Song, W., Volosin, M., Cragnolini, A. B., Hempstead, B. L., & Friedman, W. J. (2010). ProNGF induces PTEN via p75NTR to suppress Trk-mediated survival signaling in brain neurons. The Journal of Neuroscience, 30, 15608–15615.
Spuch, C., & Carro, E. (2011). The p75 neurotrophin receptor localization in blood-CSF barrier: Expression in choroid plexus epithelium. BMC Neuroscience, 12, 39.
Tabaton, M., Zhu, X., Perry, G., Smith, M. A., & Giliberto, L. (2010). Signaling effect of amyloid-beta(42) on the processing of AbetaPP. Experimental Neurology, 221, 18–25.
Tiernan, C. T., Ginsberg, S. D., He, B., Ward, S. M., Guillozet-Bongaarts, A. L., Kanaan, N. M., Mufson, E. J., & Counts, S. E. (2018). Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer’s disease. Neurobiology of Disease, 117, 125–136.
Vicario, A., Kisiswa, L., Tann, J. Y., Kelly, C. E., & Ibanez, C. F. (2015). Neuron-type-specific signaling by the p75NTR death receptor is regulated by differential proteolytic cleavage. Journal of Cell Science, 128, 1507–1517.
Wang, Y. J., Wang, X., Lu, J. J., Li, Q. X., Gao, C. Y., Liu, X. H., Sun, Y., Yang, M., Lim, Y., Evin, E., Zhong, J. H., Masters, C., & Zhou, X. F. (2011). p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain. The Journal of Neuroscience, 31, 2292–2304. Epub ahead of print.
Wang, Y.-R., Wang, J., Liu, Y.-H., Hu, G.-L., Gao, C.-Y., Wang, Y.-J., Zhou, X.-F., & Zeng, F. (2018). Cysteine-rich repeat domains 2 and 4 are amyloid-β binding domains of neurotrophin receptor p75NTR and potential targets to block amyloid-β neurotoxicity. Journal of Alzheimer’s Disease, 63, 139–147.
Wong, L. W., Tann, J. Y., Ibanez, C. F., & Sajikumar, S. (2019). The p75 neurotrophin receptor is an essential mediator of impairments in hippocampal-dependent associative plasticity and memory induced by sleep deprivation. The Journal of Neuroscience, 39, 5452–5465.
Yang, T., Liu, H., Tran, K. C., Leng, A., Massa, S. M., & Longo, F. M. (2020a). Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice. Acta Neuropathologica Communications, 8, 156.
Yang, T., Tran, K. C., Zeng, A. Y., Massa, S. M., & Longo, F. M. (2020b). Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies. Scientific Reports, 10, 20322.
Yao, X. Q., Jiao, S. S., Saadipour, K., Zeng, F., Wang, Q. H., Zhu, C., Shen, L. L., Zeng, G. H., Liang, C. R., Wang, J., Liu, Y. H., Hou, H. Y., Xu, X., Su, Y. P., Fan, X. T., Xiao, H. L., Lue, L. F., Zeng, Y. Q., Giunta, B., Zhong, J. H., Walker, D. G., Zhou, H. D., Tan, J., Zhou, X. F., & Wang, Y. J. (2015). p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer’s disease. Molecular Psychiatry, 20, 1301–1310.
Zanin, J. P., Abercrombie, E., & Friedman, W. J. (2016). Proneurotrophin-3 promotes cell cycle withdrawal of developing cerebellar granule cell progenitors via the p75 neurotrophin receptor. eLife, 5, e16654.
Zanin, J. P., Verpeut, J. L., Li, Y., Shiflett, M. W., Wang, S. S. H., Santhakumar, V., & Friedman, W. J. (2019). The p75NTR influences cerebellar circuit development and adult behavior via regulation of cell cycle duration of granule cell progenitors. The Journal of Neuroscience, 39, 9119–9129.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Shen, LL., Zeng, F., Saadipour, K., Lu, JJ., Zhou, XF., Wang, YJ. (2022). p75NTR: A Molecule with Multiple Functions in Amyloid-β Metabolism and Neurotoxicity. In: Kostrzewa, R.M. (eds) Handbook of Neurotoxicity. Springer, Cham. https://doi.org/10.1007/978-3-031-15080-7_28
Download citation
DOI: https://doi.org/10.1007/978-3-031-15080-7_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15079-1
Online ISBN: 978-3-031-15080-7
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences